Here's Why Everybody's Talking About Scholar Rock Right Now [Yahoo! Finance]
Scholar Rock Holding Corporation (SRRK)
Last scholar rock holding corporation earnings: 11/12 07:30 am
Check Earnings Report
Company Research
Source: Yahoo! Finance
The market was reacting to surprisingly positive news regarding the clinical-stage drugmaker's lead candidate, apitegromab. If you're like the vast majority of individual investors, you've never heard of Scholar Rock, apitegromab, or the muscle-wasting disease it could treat. Here's a quick look at the results that excited savvy biotech investors to see if the stock can continue climbing. Scholar Rock's surprising success Apitegromab is an antibody that binds to another protein called myostatin, which normally works to limit muscle growth. It's being tested in the phase 3 Sapphire trial, which enrolled nonambulatory patients with type 2 and type 3 spinal muscular atrophy (SMA). SMA is a genetic disorder that leads to a loss of motor neurons, which isn't great for the muscles they're attached to. Spinraza from Biogen and Evrysdi from Roche can prevent motor neurons from quitting, but they don't do anything to help rebuild muscle. The Sapphire study enrolled 156 patients ages
Show less
Read more
Impact Snapshot
Event Time:
SRRK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SRRK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SRRK alerts
High impacting Scholar Rock Holding Corporation news events
Weekly update
A roundup of the hottest topics
SRRK
News
- Q4 2024 Scholar Rock Holding Corp Earnings Call [Yahoo! Finance]Yahoo! Finance
- Scholar Rock Reports Full Year 2024 Financial Results and Highlights Business ProgressBusiness Wire
- Scholar Rock to Participate in Upcoming Investor Conferences [Yahoo! Finance]Yahoo! Finance
- Scholar Rock to Participate in Upcoming Investor ConferencesBusiness Wire
- Scholar Rock to Present Additional Clinical Data from the Phase 3 SAPPHIRE Trial at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference [Yahoo! Finance]Yahoo! Finance
SRRK
Earnings
- 11/12/24 - Miss
SRRK
Sec Filings
- 3/12/25 - Form 4
- 3/12/25 - Form 4
- 3/12/25 - Form 4
- SRRK's page on the SEC website